Flying solo: Chemotherapy without radiation for primary CNS lymphoma

Journal of Clinical Oncology

Volumn 31, Issue 25, 2013, Pages 3051-3053

  Batchelor, Tracy T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; ETOPOSIDE; METHOTREXATE; RITUXIMAB; TEMOZOLOMIDE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CYTOPENIA; DELAYED NEUROTOXICITY; DRUG FATALITY; EDITORIAL; EVENT FREE SURVIVAL; HUMAN; INDUCTION CHEMOTHERAPY; MONOTHERAPY; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; OPTIMAL DRUG DOSE; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; SALVAGE THERAPY; SEPSIS; CENTRAL NERVOUS SYSTEM TUMOR; MORTALITY; NONHODGKIN LYMPHOMA; SKULL IRRADIATION; BRAIN RADIATION; CANCER CHEMOTHERAPY; NEUROPSYCHOLOGICAL TEST;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CRANIAL IRRADIATION; CYTARABINE; ETOPOSIDE; HUMANS; LYMPHOMA, NON-HODGKIN;

EID: 84886504152     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.48.9138     Document Type: Editorial

References (18)

1. Glantz MJ, Cole BF, Recht L, et al: High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary? J Clin Oncol 16:1561-1567, 1998 (Pubitemid 28175781)
2. Thiel E, Korfel A, Martus P, et al: High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): A phase 3, randomised, non-inferiority trial. Lancet Oncol 11:1036-1047, 2010
3. Correa DD, Shi W, Abrey LE, et al: Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol 14:101-108, 2012
4. Shah GD, Yahalom J, Correa DD, et al: Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25:4730-4735, 2007 (Pubitemid 350086474)
5. Monje ML, Mizumatsu S, Fike JR, et al: Irradiation induces neural precursor-cell dysfunction. Nat Med 8:955-962, 2002 (Pubitemid 35033699)
6. Juergens A, Pels H, Rogowski S, et al: Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Ann Neurol 67:182-189, 2010
7. Rubenstein JL, Hsi ED, Johnson JL, et al: Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202). J Clin Oncol 31:3061-3068, 2013
8. Abrey LE, Batchelor TE, Ferreri AJ, et al: Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23:5034-5043, 2005 (Pubitemid 46224010)
9. Reni M, Mason W, Zaja F, et al: Salvage chemotherapy with temozolomide in primary CNS lymphomas: Preliminary results of a phase II trial. Eur J Cancer 40:1682-1688, 2004 (Pubitemid 38902903)
10. Batchelor TT, Grossman SA, Mikkelsen T, et al: Rituximab monotherapy for patients with recurrent primary CNS lymphoma. Neurology 76:929-930, 2011
11. Gerstner ER, Carson KA, Grossman SA, et al: Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation. Neurology 70:401-402, 2008 (Pubitemid 351653404)
12. Soussain C, Hoang-Xuan K, Taillandier L, et al: Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse- Thérapie Cellulaire. J Clin Oncol 26:2512-2518, 2008
13. Ferreri AJ, Reni M, Foppoli M, et al: High-dose cytarabine plus highdose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: A randomised phase 2 trial. Lancet 374:1512-1520, 2009
14. DeAngelis LM, Seiferheld W, Schold SC, et al: Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 20:4643-4648, 2002 (Pubitemid 36025280)
15. Illerhaus G, Fritsch K, Egerer G, et al: Sequential high dose immunochemotherapy followed by autologous peripheral blood stem cell transplantation for patients with untreated primary central nervous system lymphoma: A multicentre study by the Collaborative PCNSL Study Group Freiburg. Blood 120, 2012 (abstr 302)
16. Correa DD, Maron L, Harder H, et al: Cognitive functions in primary central nervous system lymphoma: Literature review and assessment guidelines. Ann Oncol 18:1145-1151, 2007 (Pubitemid 47244358)
17. Braaten KM, Betensky RA, de Leval L, et al: BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res 9:1063-1069, 2003 (Pubitemid 36329149)
18. Levy O, Deangelis LM, Filippa DA, et al: Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. J Clin Oncol 112:151-156, 2008